#Neurology #NeurologicalDiseases @thelancetneuro #ChronicMigraine is associated with substantial disease burden. Atogepant 30 mg twice a day & 60 mg once per day showed clinically relevant reductions in MMDs across 12 weeks in chronic migraine patients. Both atogepant doses were well tolerated, consistent with the known safety profile of atogepant.

#neurobiology #NeurologicalDiseases #dopamine is a type of neurotransmitter that can provide an intense feeling of reward. It has been a long-standing assumption that most, if not all, #dopamineneurons solely respond to rewards or reward-predicting cues & control the movement. DN More Diverse than Previously Thought
📌 https://www.genengnews.com/topics/translational-medicine/dopamine-neurons-more-diverse-than-previously-thought/
📌 https://www.nature.com/articles/s41593-023-01401-9

Referenced link: https://medicalxpress.com/news/2022-10-radiotracer-important-contributor-neurological-diseases.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2022-10-radiotracer-important-contributor-neurological-diseases.html

Originally posted by Phys.org / @physorg_com@twitter.com: https://twitter.com/medical_xpress/status/1577742181464510466#m

RT by @physorg_com: Radiotracer that detects important contributor to #neurologicaldiseases is tested for the first time in humans https://link.springer.com/article/10.1007/s00259-022-05980-w https://medicalxpress.com/news/2022-10-radiotracer-important-contributor-neurological-diseases.html